Assumeupper management of the organization is interested in understanding the impact its branding and competitive strategies have on consumer choice, as well as the impact of the bargaining power of consumers in the health care market, especially on your products and services.
Preparea 1,050-word summary of branding and competitive strategies impact on consumer choice and bargaining power on ECRHS.
Part I: Branding Strategy Impact
Analyzethe impact that the current ECRHS brand has on consumer choice of its products and services. In your analysis, consider the following:
What is the current branding strategy of ECRHS?
How are the organization and its brand(s) perceived in the market?
Are there any negative impacts of legal cases against the organization within the community or its consumers? How might this impact their choice of a health care provider?
How have your acquisitions of other health care facilities impacted your brand image and hence consumer choice of your organization?
How has your handling of the COVID-19 pandemic impacted your brand image?
What impact do your branding strategies have on consumer choice and bargaining power?
Part II: Competitive Strategies Impact
Analyzethe impact that the current ECRHS competitors have on consumer choice of its products and services. In your analysis, consider the following:
Who are?the 3 largest competitors, and how do their offerings differ from those of ECRHS?
What share of the market do the competitors hold?
What are the threats of new entrants to the market and the organization?
What is the threat of competitive/substitute products/services to the organization?
What is the bargaining power of customers in the market?
How does this bargaining power impact consumer choice in the market and for ECRHS?
Citeat least 3 reputable references to support your assignment (e.g., trade or industry publications, government or agency sites, scholarly works, or other sources of similar quality).
Formatyour citations per APA guidelines.
Drug companies are pursuing collaborative efforts with other companies to manage in the world of pharmacogenomics and individualized medicine.
Respond to the following in a minimum of 175 words:
What are some examples of these collaborative efforts by pharmaceutical companies (e.g., Accelerated Medical Partnership (AMP) program)?
What are some examples of the value in partnerships and collaborations in health care service systems?